Traditional delivery methods often face challenges such as poor bioavailability, rapid degradation of therapeutic agents, and nonspecific distribution that can lead to adverse effects. Enhanced delivery using nanotechnology addresses these issues by offering targeted delivery, controlled release, and improved stability of therapeutic agents.
